Stockscreener 앱 받기
7.21
0.13%
-0.05
시간 외 거래:
7.21
전일 마감가:
$7.16
열려 있는:
$7.25
하루 거래량:
682.11K
Relative Volume:
0.17
시가총액:
$324.60M
수익:
$123.87M
순이익/손실:
$62.49M
주가수익비율:
4.3187
EPS:
1.6695
순현금흐름:
$-87.53M
1주 성능:
+4.24%
1개월 성능:
-2.31%
6개월 성능:
+117.35%
1년 성능:
+59.97%
1일 변동 폭
$7.055
$7.33
1주일 범위
$6.66
$7.33
52주 변동 폭
$2.71
$8.85
아제너스 Stock (AGEN) Company Profile
명칭
Agenus Inc
전화
781-674-4410
주소
3 FORBES ROAD, LEXINGTON, MA
Compare AGEN vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AGEN
Agenus Inc
|
7.21 | 312.44M | 123.87M | 62.49M | -87.53M | 1.6695 |
VRTX
Vertex Pharmaceuticals Inc
|
513.35 | 130.64B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
774.83 | 80.46B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
985.16 | 61.58B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.65 | 57.48B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
195.92 | 43.68B | 742.00K | -1.37B | -1.07B | -7.0731 |
아제너스 Stock (AGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-04 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2024-07-19 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-07-18 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-07-18 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-06-06 | 개시 | Robert W. Baird | Outperform |
| 2023-02-28 | 재개 | H.C. Wainwright | Buy |
| 2022-09-28 | 개시 | SMBC Nikko | Outperform |
| 2021-12-16 | 개시 | H.C. Wainwright | Buy |
| 2019-11-19 | 재개 | B. Riley FBR | Buy |
| 2019-04-22 | 개시 | B. Riley FBR | Buy |
| 2016-10-28 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2016-10-27 | 재확인 | Maxim Group | Buy |
| 2016-03-11 | 업그레이드 | Maxim Group | Hold → Buy |
| 2015-12-16 | 개시 | Jefferies | Buy |
| 2015-10-27 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2015-07-27 | 재확인 | MLV & Co | Buy |
| 2015-06-11 | 개시 | Oppenheimer | Outperform |
| 2015-01-12 | 재확인 | Maxim Group | Buy |
| 2015-01-09 | 재확인 | MLV & Co | Buy |
| 2015-01-09 | 재확인 | Maxim Group | Buy |
| 2014-12-19 | 재확인 | Maxim Group | Buy |
| 2014-05-08 | 재확인 | Maxim Group | Buy |
| 2014-03-14 | 재확인 | MLV & Co | Buy |
| 2013-10-08 | 재확인 | Maxim Group | Buy |
| 2012-01-05 | 개시 | William Blair | Outperform |
| 2011-12-01 | 개시 | Global Hunter Securities | Buy |
모두보기
아제너스 주식(AGEN)의 최신 뉴스
September Stakeholder Webcast on ROBBIN Phase 3 and Neoadjuvant ImmunotherapyAgenus - Oncodaily
Agenus Inc Share PriceAGEN, RNS News, Articles, Quotes, & Charts (NASDAQ:AGEN) - Proactive financial news
AGEN S-3 FilingsAgenus Inc. SEC S-3 - stocktitan.net
Agenus Inc. (AGEN) Shareholder/Analyst CallSlideshow (NASDAQ:AGEN) 2026-09-11 - Seeking Alpha
BOT+BAL: Three-Year Overall Survival Data in Recurrent Ovarian Cancer – Agenus - Oncodaily
Agenus to Present Three-Year Overall Survival Data for BOT+BAL in Recurrent Ovarian Cancer at IGCS 2026 - BioSpace
Agenus to Present 3-Year Overall Survival Data for BOT+BAL in Recurrent Ovarian Cancer at IGCS 2026 - Oncodaily
GOOG: Alphabet IncOrdinary SharesClass C Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Agenus Company Profile & Introduction - moomoo.com
Agenus Stock Price Forecast. Should You Buy AGEN? - StockInvest.us
Agenus Inc (AGEN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Agenus to Participate in Upcoming September Investor Conferences - Business Wire
Immigrant Entrepreneur Garo H. Armen Of Agenus Inc. Riccardo Braschi (I0EURkuuPl) - Mshale
New Phase 2 NEST Results Support Neoadjuvant BOT+BAL in Colon Cancer – Agenus - Oncodaily
Agenus reports survival data for colorectal cancer treatment By Investing.com - Investing.com South Africa
Agenus Announces Peer-Reviewed Publication Linking BOT+BAL’s Durable Survival in MSS Metastatic Colorectal Cancer to Its Distinct Immune-Priming Mechanism - Yahoo Finance
Agenus reports survival data for colorectal cancer treatment - investing.com
Agenus Inc: Shareholders Revolt Over Executive Pay! My Thoughts. Tampa Bay Rays (VzxHMd1TNP) - Mshale
Agenus Inc.AGEN Stock Chart Technical Analysis For 09-21-2020 Sporting Cp (0os72ROBex) - Mshale
Agenus Announces Updated NEST Phase 2 Publication Reporting Deep Pathologic Responses and No Observed Recurrences with Neoadjuvant BOT+BAL in Resectable Colon Cancer - Yahoo Finance
Agenus Reports No Recurrences and Deep Pathologic Responses With Neoadjuvant BOT+BAL in Resectable Colon Cancer - Oncodaily
🔴 Agenus Inc. AGEN Stock Trading Facts 🔴 Gianna Nannini (9cYwfB9Crl) - Mshale
Agenus | Learn How I Turned $15,253 Into $1,613,442 Trading Biotech Stocks Donald Gibb (Gf1su3sDdD) - Mshale
AGEN Stock Analysis | Agenus Inc Stock Update & Chart Breakdown Traffic Stop (vDz5v0ltyg) - Mshale
Bold Move By Agenus: Cutting Costs By 60% To Focus On Groundbreaking Cancer Treatments Nikoloz Basilashvili (41VwNJliWR) - Mshale
A.G.E.N.U.S. 8-K: My Take On The C.F.I.U.S. Delay Ctv News Ottawa (HFy9tZJhiU) - Mshale
Why Agenus (AGEN Stock) Just Rocketed Up—Buy Now Or Too Late? Cigarette (l3DDhgoK4D) - Mshale
Insider Trading AGEN Agenus Inc 2021 05 18 Blowing Dust Advisory (aETsN3n1J0) - Mshale
Agenus Inc AGEN CEO Garo Armen On Q4 2019 Results David Muir (NjcFXnx049) - Mshale
Agenus Inc (AGEN) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
AGEN Stock TUESDAY MADNESS! (news Update) Agenus Stock Analysis Best Broker Review Challenge Cup Final 2026 (5MyfQl06Kh) - Mshale
Agenus Inc. (AGEN) Latest Stock News & Headlines - Yahoo Finance
Agenus extends $24.75 million loan maturity, adjusts payment terms with Ocean 1181 - Investing.com
Form 8K Agenus Inc For: 18 August By Investing.com - Investing.com South Africa
Agenus Extends $24.75M Term Loan to 2029 at 13% With Ocean 1181; Partly Payable in Stock - TradingView
Agenus (NASDAQ: AGEN) to pay part of 13% loan interest in stock - Stock Titan
Agenus Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
AGEN Q2 2026 Earnings: EPS Misses Estimates by 119.61% as Shares Slide 2.32%EBITDA Estimate Trend - Vinanet
AGENUS INC SEC Filing (Aug 17, 2026) - Stock Titan
Agenus Puts Its BOT+BAL Cancer Combo To The Test - Finimize
Renaissance Technologies LLC Sells 257,900 Shares of Agenus Inc. $AGEN - MarketBeat
HC Wainwright Estimates Agenus' Q3 Earnings (NASDAQ:AGEN) - MarketBeat
Agenus (AGEN) awards 1.97M performance stock options to CEO Garo Armen - Stock Titan
Agenus (NASDAQ: AGEN) awards 1.97M performance-tied stock options to CEO - Stock Titan
Agenus Announces Three-Year Survival Data from Phase 1b BOT+BAL S - The National Law Review
Form 8K Agenus Inc For: 11 August By Investing.com - Investing.com South Africa
아제너스 (AGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.23%
2.40%
자본화:
|
볼륨(24시간):